Amedisys, Inc.
AMED
$94.50
$0.230.24%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 43.23M | 82.93M | 91.98M | -20.59M | -9.75M |
Total Depreciation and Amortization | 60.46M | 59.31M | 58.38M | 58.03M | 57.64M |
Total Amortization of Deferred Charges | 991.00K | 991.00K | 991.00K | 991.00K | 991.00K |
Total Other Non-Cash Items | 77.09M | 41.54M | 49.89M | 151.96M | 151.51M |
Change in Net Operating Assets | 39.90M | 26.92M | -105.00M | -85.70M | -63.21M |
Cash from Operations | 221.67M | 211.70M | 96.23M | 104.69M | 137.19M |
Capital Expenditure | -6.55M | -7.33M | -6.93M | -6.94M | -5.62M |
Sale of Property, Plant, and Equipment | -- | 36.00K | 36.00K | 136.00K | 136.00K |
Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | -350.00K |
Divestitures | -- | 0.00 | 0.00 | 0.00 | 47.79M |
Other Investing Activities | -1.81M | -1.83M | -831.00K | -7.10M | -6.89M |
Cash from Investing | -8.36M | -9.12M | -7.73M | -13.90M | 35.06M |
Total Debt Issued | -- | 0.00 | 0.00 | 15.00M | 23.00M |
Total Debt Repaid | -37.36M | -36.63M | -33.40M | -44.64M | -99.01M |
Issuance of Common Stock | 309.00K | 88.00K | 873.00K | 1.89M | 2.70M |
Repurchase of Common Stock | -6.15M | -6.96M | -7.24M | -5.84M | -6.53M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -5.72M | -7.64M | -2.54M | -5.59M | -7.68M |
Cash from Financing | -48.92M | -51.14M | -42.31M | -39.18M | -87.52M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 164.38M | 151.43M | 46.20M | 51.60M | 84.73M |